Underwriter
What Is a Biotech IPO? How Clinical-Stage Companies Go Public and What Investors Should Know
The biotech IPO market is one of the most distinctive segments of the public equity landscape. Clinical-stage biotech companies routinely go public with no revenue, no approved products, and development timelines measured in years — and retail investors who understand how the IPO process works and what to look for in a biotech prospectus are…
